Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **folate biosynthesis pathway** encompasses all enzymatic steps required for the de novo production of tetrahydrofolic acid and its derivatives from simple precursors such as GTP, para‐aminobenzoic acid, and glutamate. This multi-step process involves several key enzymes—including guanine cyclohydrolase I, dihydroneopterin aldolase, hydroxymethyl-dihydropteridine pyrophosphokinase, dihydropteroate synthase (DHPS), dihydrofolate synthase (DHFS), and dihydrofolate reductase (DHFR)—that sequentially convert these substrates into functional forms of folates necessary for one-carbon transfer reactions critical in nucleotide biosynthesis and amino acid metabolism.[1][2] In humans and other animals that cannot synthesize folates de novo but rely on dietary intake or gut microbiota sources,[6], disruption or inhibition of this bacterial/plant/fungal-specific synthetic route forms the basis for several classes of antimicrobial agents—most notably sulfonamides targeting DHPS and trimethoprim/methotrexate targeting DHFR.[2][5] These drugs exploit differences between prokaryotic/eukaryotic enzyme structures but can also affect rapidly dividing host cells if selectivity is insufficient.[5] In summary: “Folate synthesis” describes an essential metabolic network rather than a discrete molecular target suitable for structured drug-target databases. For precise pharmacological information or therapeutic intervention details it is necessary to refer instead to individual components such as “Dihydrofolate reductase” or “Dihydropteroate synthase.”
Again, mechanisms relate to inhibition of specific enzymes within the folate biosynthesis pathway. - Competitive inhibition of para‐aminobenzoic acid incorporation by sulfonamides at dihydropteroate synthase - Inhibition of dihydrofolate reductase activity by trimethoprim/methotrexate/pyrimethamine leading to depletion of tetrahydrofolate pools required for DNA/RNA/protein synthesis
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Folate biosynthesis pathway.